$153MSeries B, 7 August 2025
Funds will advance STX-001 in the clinic and expand its mRNA genetic circuit platform.
- Amount
- $153M
- Stage
- Series B
- Announced
- 7 August 2025
- Lead
- Kinnevik
- Other investors
- Regeneron Ventures, ICONIQ, Amgen Ventures, Alderline Group, JIC-VGI, LG Technology Ventures, Gradiant Corporation, FPV Ventures, Playground Global, Eli Lilly and Company
- Use of funds
- Funds will advance STX-001 in the clinic and expand its mRNA genetic circuit platform.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pi techstartups.com
Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pi businesswire.com